Breaking the (Genetic) Code of Pediatric Medulloblastoma
Yiping He, PhD, received the 2014 AACR-Aflac, Inc. Career Development Award for Pediatric Cancer Research to study how medulloblastoma,...
Yiping He, PhD, received the 2014 AACR-Aflac, Inc. Career Development Award for Pediatric Cancer Research to study how medulloblastoma,...
Cancer is often described as a disease of old age, but over 15,000 children are diagnosed with cancer each...
Cancer treatment is a double-edged sword. Intense or multi-pronged treatment may lead to better killing of tumor cells, but...
Earlier this year, a study published in Cancer Discovery, a journal of the American Association for Cancer Research (AACR),...
A team of mathematicians are designing an app that could help predict the likelihood of prostate cancer relapse.
As a monthly staple on this blog, we feature the editors’ picks from the 10 journal issues published by...
A team of researchers from Australia has shown that an optical fiber-tip probe that can detect the pH of...
Cancer immunotherapy refers to treatments that can unleash the power of a patient’s immune system to fight his or...
When faced with a cancer diagnosis, patients often find themselves asking, “How long will I live? Which treatments will...
Researchers are examining the gut microbiome to find better ways to diagnose and manage colorectal cancer.
Highlights from Cancer Today's summer 2024 issue, including treatment-induced heart conditions, profile of Brian Jones, and more.
April symbolizes a progressive time for cancer researchers around the world. From April 1-5, over 20,000 cancer scientists will...
Early-career investigators play an important role in advancing cancer research, helping spur new discoveries and the translation of these...
In 2019, research continued to drive progress across the spectrum of cancer care in the form of new and...
Immunotherapy is a form of cancer treatment that helps a patient’s own immune system recognize and attack cancer cells....
As social media continues to rapidly grow as a leading source of news and information, it has evolved to...
Amy Bianchi discovered a lump in her breast when her first child was 18 months old. She was diagnosed...
Seven immune checkpoint inhibitors, targeting the PD-1, PD-L1, or CTLA-4 proteins, are currently approved for the treatment of cancer....
Studies presented at this year’s San Antonio Breast Cancer Symposium shed light on new investigational therapies for patients with...
According to the White House, this was the first time a group this expansive and diverse met under a...
Last week, the U.S. Food and Drug Administration (FDA) added a new therapeutic to the armamentarium for oncologists treating...
Last week, the U.S. Food and Drug Administration (FDA) announced that it had approved expanding the use of the...
Today, the American Association for Cancer Research (AACR) released its ninth annual Cancer Progress Report. The report highlights how...
For the third year running, the American Association for Cancer Research (AACR) has been selected as the beneficiary of...
Since 1996, the Associate Member Council (AMC) has served as the leadership body for associate members of the American...
Clinical trials are an essential part of cancer research. They ensure that scientific discoveries are translated into advances in...
In less than a month, the AACR Annual Meeting 2018 will kick off in Chicago, Illinois. The meeting is...
Today is International Day of Women and Girls in Science, a United Nations initiative aimed at encouraging full and...
Head and neck cancers encompass a large group of malignancies that originate in the nasal cavity, sinuses, lips, mouth,...
The FDA has approved nivolumab for treating patients with recurrent or metastatic squamous cell carcinoma of the head...